• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蒙特利尔认知评估量表对于鉴别阿尔茨海默病、额颞叶痴呆、路易体痴呆和血管性痴呆是否是一项有价值的测试?

Is Montreal Cognitive Assessment a valuable test for the differentiation of Alzheimer's disease, frontotemporal dementia, dementia with Lewy body, and vascular dementia?

作者信息

Afrashteh Fatemeh, Almasi-Dooghaee Mostafa, Kamyari Naser, Rajabi Rayan, Baradaran Hamid Reza

机构信息

Iran University of Medical Sciences, School of Medicine, Tehran, Iran.

Iran University of Medical Sciences, Department of Neurology, Firoozgar Clinical Research Development Center (FCRDC), Tehran, Iran.

出版信息

Dement Neuropsychol. 2024 Aug 26;18:e20230124. doi: 10.1590/1980-5764-DN-2023-0124. eCollection 2024.

DOI:10.1590/1980-5764-DN-2023-0124
PMID:39193467
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11348881/
Abstract

UNLABELLED

Dementia is one of the growing diseases in the world and has different types based on its definition. The Montreal Cognitive Assessment (MoCA) test has been employed to screen patients with dementia, cognitive impairment, and disruption of daily activities.

OBJECTIVE

This study examined the diagnostic value of the total MoCA score and its subscores in differentiating Alzheimer's disease (AD), frontotemporal dementia (FTD), dementia with Lewy body (DLB), and vascular dementia (VaD).

METHODS

A total of 241 patients (AD=110, FTD=90, DLB=28, and VaD=13) and 59 healthy persons, who were referred to a dementia clinic with memory impairment in Firoozgar Hospital, were included in this study. MoCA tests were performed in all patients and normal persons.

RESULTS

By using the receiver operating characteristic (ROC) curve and measuring the area under the curve (AUC) for the total MoCA score in each group, AUC was 0.616, 0.681, 0.6117, and 0.583 for differentiating AD, FTD, DLB, and VaD patients, respectively. Among the groups, just the VaD group showed no significant usefulness in using the total MoCA score to differentiate it. To compare MoCA subscores, AD patients had higher scores in digit span, literal fluency, and abstraction but lower delayed recall scores compared with FTD patients.

CONCLUSION

The total MoCA score and its subscores could not differentiate people with different types of dementia in the setting of screening.

摘要

未标注

痴呆症是世界上日益增多的疾病之一,根据其定义有不同类型。蒙特利尔认知评估(MoCA)测试已被用于筛查患有痴呆症、认知障碍和日常活动中断的患者。

目的

本研究探讨MoCA总分及其子分数在区分阿尔茨海默病(AD)、额颞叶痴呆(FTD)、路易体痴呆(DLB)和血管性痴呆(VaD)方面的诊断价值。

方法

本研究纳入了共241例患者(AD = 110例,FTD = 90例,DLB = 28例,VaD = 13例)以及59名健康人,这些患者和健康人因记忆障碍被转诊至菲罗兹加尔医院的痴呆症诊所。所有患者和正常人都进行了MoCA测试。

结果

通过使用受试者工作特征(ROC)曲线并测量每组中MoCA总分的曲线下面积(AUC),区分AD、FTD、DLB和VaD患者时,AUC分别为0.616、0.681、0.6117和0.583。在这些组中,只有VaD组在使用MoCA总分进行区分时没有显示出显著的有效性。为了比较MoCA子分数,与FTD患者相比,AD患者在数字广度、文字流畅性和抽象能力方面得分较高,但延迟回忆得分较低。

结论

在筛查背景下,MoCA总分及其子分数无法区分不同类型痴呆症患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/978f/11348881/076e61b57cee/1980-5764-DN-18-e20230124-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/978f/11348881/168c93036ad3/1980-5764-DN-18-e20230124-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/978f/11348881/076e61b57cee/1980-5764-DN-18-e20230124-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/978f/11348881/168c93036ad3/1980-5764-DN-18-e20230124-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/978f/11348881/076e61b57cee/1980-5764-DN-18-e20230124-gf02.jpg

相似文献

1
Is Montreal Cognitive Assessment a valuable test for the differentiation of Alzheimer's disease, frontotemporal dementia, dementia with Lewy body, and vascular dementia?蒙特利尔认知评估量表对于鉴别阿尔茨海默病、额颞叶痴呆、路易体痴呆和血管性痴呆是否是一项有价值的测试?
Dement Neuropsychol. 2024 Aug 26;18:e20230124. doi: 10.1590/1980-5764-DN-2023-0124. eCollection 2024.
2
Montreal Cognitive Assessment and Mini-Mental State Examination performance in patients with mild-to-moderate dementia with Lewy bodies, Alzheimer's disease, and normal participants in Taiwan.台湾地区轻度至中度路易体痴呆、阿尔茨海默病患者和正常参与者的蒙特利尔认知评估和简易精神状态检查表现。
Int Psychogeriatr. 2013 Nov;25(11):1839-48. doi: 10.1017/S1041610213001245. Epub 2013 Aug 7.
3
Role of semiquantitative assessment of regional binding potential in 123I-FP-CIT SPECT for the differentiation of frontotemporal dementia, dementia with Lewy bodies, and Alzheimer's dementia.123I-FP-CIT SPECT 中局部结合势半定量评估在鉴别额颞叶痴呆、路易体痴呆和阿尔茨海默病中的作用。
Clin Nucl Med. 2015 Jan;40(1):e27-33. doi: 10.1097/RLU.0000000000000554.
4
Comparisons of clinical symptoms in biomarker-confirmed Alzheimer's disease, dementia with Lewy bodies, and frontotemporal dementia patients in a local memory clinic.当地记忆诊所中生物标志物确诊的阿尔茨海默病、路易体痴呆和额颞叶痴呆患者临床症状的比较。
Psychogeriatrics. 2015 Dec;15(4):235-41. doi: 10.1111/psyg.12103. Epub 2014 Dec 23.
5
The cerebrospinal fluid amyloid beta42/40 ratio in the differentiation of Alzheimer's disease from non-Alzheimer's dementia.脑脊液淀粉样蛋白β42/40 比值在阿尔茨海默病与非阿尔茨海默病痴呆的鉴别诊断中的作用。
Curr Alzheimer Res. 2010 Aug;7(5):470-6. doi: 10.2174/156720510791383796.
6
Detection and Differentiation of Frontotemporal Dementia and Related Disorders From Alzheimer Disease Using the Montreal Cognitive Assessment.
Alzheimer Dis Assoc Disord. 2016 Jul-Sep;30(3):258-63. doi: 10.1097/WAD.0000000000000119.
7
The effects of behavioral and psychological symptoms on caregiver burden in frontotemporal dementia, Lewy body dementia, and Alzheimer's disease: clinical experience in China.行为和心理症状对额颞叶痴呆、路易体痴呆及阿尔茨海默病患者照料者负担的影响:中国的临床经验
Aging Ment Health. 2017 Jun;21(6):651-657. doi: 10.1080/13607863.2016.1146871. Epub 2016 Feb 16.
8
Screening for Cognitive Impairment in Movement Disorders: Comparison of the Montreal Cognitive Assessment and Quick Mild Cognitive Impairment Screen in Parkinson's Disease and Lewy Body Dementia.运动障碍中认知障碍的筛查:帕金森病和路易体痴呆中蒙特利尔认知评估与快速轻度认知障碍筛查的比较
J Alzheimers Dis Rep. 2024 Jun 21;8(1):971-980. doi: 10.3233/ADR-230207. eCollection 2024.
9
Conversion Between the Mini-Mental State Examination and the Montreal Cognitive Assessment for Patients With Different Forms of Dementia.不同类型痴呆患者简易精神状态检查量表与蒙特利尔认知评估量表的转换。
J Am Med Dir Assoc. 2022 Dec;23(12):1986-1989.e1. doi: 10.1016/j.jamda.2022.03.018. Epub 2022 May 11.
10
Addition of MHPG to Alzheimer's disease biomarkers improves differentiation of dementia with Lewy bodies from Alzheimer's disease but not other dementias.添加 MHPG 可改善路易体痴呆与阿尔茨海默病的生物标志物的区分,但不能改善其他类型痴呆的区分。
Alzheimers Dement. 2014 Jul;10(4):448-455.e2. doi: 10.1016/j.jalz.2013.05.1775. Epub 2013 Nov 13.

本文引用的文献

1
The role of transcranial sonography in differentiation of dementia subtypes: an introduction of a new diagnostic method.经颅超声检查在痴呆亚型鉴别中的作用:一种新诊断方法介绍
Neurol Sci. 2021 Jan;42(1):275-283. doi: 10.1007/s10072-020-04566-4. Epub 2020 Jul 8.
2
Frontotemporal Dementia: Neuropathology, Genetics, Neuroimaging, and Treatments.额颞叶痴呆:神经病理学、遗传学、神经影像学和治疗。
Psychiatr Clin North Am. 2020 Jun;43(2):331-344. doi: 10.1016/j.psc.2020.02.006. Epub 2020 Apr 8.
3
2020 Alzheimer's disease facts and figures.
2020年阿尔茨海默病事实与数据。
Alzheimers Dement. 2020 Mar 10. doi: 10.1002/alz.12068.
4
Frontotemporal dementia.额颞叶痴呆
Handb Clin Neurol. 2019;167:279-299. doi: 10.1016/B978-0-12-804766-8.00015-7.
5
Clinical and Imaging Characteristics Associated with Color Vision Impairment in Lewy Body Disease.路易体病中与色觉障碍相关的临床和影像学特征
J Alzheimers Dis. 2019;72(4):1233-1240. doi: 10.3233/JAD-190727.
6
New evidence on the management of Lewy body dementia.关于路易体痴呆管理的新证据。
Lancet Neurol. 2020 Feb;19(2):157-169. doi: 10.1016/S1474-4422(19)30153-X. Epub 2019 Sep 10.
7
The economic cost of dementia: A systematic review.痴呆症的经济成本:系统综述。
Dementia (London). 2020 Nov;19(8):2637-2657. doi: 10.1177/1471301219837776. Epub 2019 Mar 25.
8
Validity and reliability of the Persian version of the Montreal Cognitive Assessment (MoCA-P) scale among subjects with Parkinson's disease.帕金森病患者中蒙特利尔认知评估量表(MoCA-P)波斯语版本的有效性和可靠性。
Appl Neuropsychol Adult. 2020 Sep-Oct;27(5):431-439. doi: 10.1080/23279095.2019.1565762. Epub 2019 Mar 1.
9
Is the Montreal Cognitive Assessment (MoCA) screening superior to the Mini-Mental State Examination (MMSE) in the detection of mild cognitive impairment (MCI) and Alzheimer's Disease (AD) in the elderly?蒙特利尔认知评估量表(MoCA)筛查在检测老年人轻度认知障碍(MCI)和阿尔茨海默病(AD)方面是否优于简易精神状态检查(MMSE)?
Int Psychogeriatr. 2019 Apr;31(4):491-504. doi: 10.1017/S1041610218001370. Epub 2018 Nov 14.
10
Dementia.痴呆。
Am J Med. 2018 Oct;131(10):1161-1169. doi: 10.1016/j.amjmed.2018.01.022. Epub 2018 Feb 6.